Evidence map›Paper›PMID 36672930›Full record

ArticleGenes2023

Marker-Assisted Recurrent Selection for Pyramiding Leaf Rust and Coffee Berry Disease Resistance Alleles in

Laura Maritza Saavedra, Eveline Teixeira Caixeta, Geleta Dugassa Barka, Aluízio Borém, Laércio Zambolim, Moysés Nascimento, Cosme Damião Cruz, Antonio Carlos Baião de Oliveira, Antonio Alves Pereira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Laura Maritza SaavedraInstituto de Biotecnologia Aplicada à Agropecuária-Bioagro, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
Eveline Teixeira CaixetaInstituto de Biotecnologia Aplicada à Agropecuária-Bioagro, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0001-8850-6273
Geleta Dugassa BarkaDepartment of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama 1888, Ethiopia.ORCID 0000-0002-1521-9705
Aluízio BorémDepartamento de Agronomia, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0003-1386-5903
Laércio ZambolimInstituto de Biotecnologia Aplicada à Agropecuária-Bioagro, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
Moysés NascimentoDepartamento de Estatística, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0001-5886-9540
Cosme Damião CruzDepartamento de Biologia Geral, Universidade Federal de Viçosa, Viçosa 36570-000, MG, Brazil.ORCID 0000-0003-3513-3391
Antonio Carlos Baião de OliveiraBrazilian Agricultural Research Corporation (Embrapa), Embrapa Coffee, Brasília 70770-901, DF, Brazil.ORCID 0000-0003-0348-8657
Antonio Alves PereiraEmpresa de Pesquisa Agropecuária de Minas Gerais-Epamig, Viçosa 36570-000, MG, Brazil.ORCID 0000-0002-4252-3913
Universidade Federal de Viçosa · BRAdama Science and Technology University · ETBrazilian Agricultural Research Corporation · BREmpresa de Pesquisa Agropecuária de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, marker-assisted recurrent selection was evaluated for pyramiding resistance gene alleles against coffee leaf rust (CLR) and coffee berry diseases (CBD) in

Indexed as

CoffeaDisease ResistanceAllelesPlant Diseasescoffee berry diseasescoffee leaf rustdurable resistancegene pyramiding

Identifiers

PMID36672930
PMCPMC9858729
OpenAlexW4315648851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.